Tela Bio Inc Expected To Post A Loss Of 20 Cents A Share: Earnings Preview

TELA Bio

06/05/2025 21:55

TELA Bio Inc TELA.OQ TELA.O is expected to show a rise in quarterly revenue when it reports  results on May 8 for the period ending March 31 2025

The Malvern Pennsylvania-based  company is expected to report a 4.6% increase in revenue to $17.36 million from $16.6 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.The company's guidance on March 20 2025, for the period ended March 31, was for revenue between $17.00 million and $18.00 million.

​LSEG's mean analyst estimate for TELA Bio Inc is for a loss of 20 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for TELA Bio Inc is $7.00​, above​ its last closing price of $1.00. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.24
-0.22
-0.23
Missed
-3.2
Sep. 30 2024
-0.42
-0.40
-0.42
Missed
-3.9
Jun. 30 2024
-0.46
-0.47
-0.51
Missed
-8.1​
Mar. 31 2024
-0.51
-0.50
-0.23
Beat
54.1
​​Dec. 31 2023
-0.42
-0.43
-0.53
Missed
-21.9
Sep. 30 2023
-0.49
-0.49
-0.45
Beat
8.5​
Jun. 30 2023
-0.53
-0.53
-0.46
Beat
13.7
Mar. 31 2023
-0.56
-0.56
-0.63
Missed
-12.7

This summary was machine generated May 6 at 20:55 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)